FGFR3 and hypochondroplasia: To explore the effectiveness of TYRA-300 in an additional model of FGFR3-related chondrodysplasia, TYRA-300 was evaluated in a Tg-CMVCre/+/Fgfr3N534K/+ mouse model of HCH (42).